Overview

Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris

Status:
Completed

Trial end date:
2012-01-03

Target enrollment:

Participant gender:

Summary

The primary objectives of the study is to show CD2475/101 40mg tablets taken once a day for 16 weeks is superior to the placebo in Change from baseline to Week 16(Last Observation Carry Forward, Intent To Treat) in inflammatory lesion counts.

Phase:

Phase 2

Details

Lead Sponsor:

Galderma
Galderma R&D

Treatments:

Doxycycline